Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Modivcare Inc. (MODV) Stock Forecast & Price Prediction United States | NASDAQ | Healthcare | Medical Care Facilities
$0.02
+0.00 (0.00%)Did MODV Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if ModivCare is one of their latest high-conviction picks.
MODV has shown a year-to-date change of 0.0% and a 1-year change of -99.2%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for MODV. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for MODV.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| May 12, 2025 | Barrington Research | Michael Petusky | Market Perform | Downgrade | $N/A |
| Mar 10, 2025 | Stephens & Co. | Raj Kumar | Equal-Weight | Maintains | $3.50 |
| Mar 7, 2025 | Barrington Research | Michael Petusky | Outperform | Maintains | $6.00 |
| Jan 14, 2025 | Barrington Research | Michael Petusky | Outperform | Maintains | $10.00 |
| Jan 13, 2025 | Lake Street | Brooks O'Neil | Buy | Maintains | $10.00 |
| Jan 10, 2025 | Stephens & Co. | Raj Kumar | Equal-Weight | Downgrade | $17.00 |
| Nov 18, 2024 | Barrington Research | Michael Petusky | Outperform | Maintains | $25.00 |
| Nov 8, 2024 | Barrington Research | Michael Petusky | Outperform | Maintains | $25.00 |
| Oct 3, 2024 | Barrington Research | Michael Petusky | Outperform | Maintains | $22.00 |
| Sep 17, 2024 | Lake Street | Brooks O'Neil | Buy | Maintains | $30.00 |
| Sep 17, 2024 | Barrington Research | Michael Petusky | Outperform | Maintains | $19.00 |
| Sep 13, 2024 | Jefferies | Brian Tanquilut | Hold | Maintains | $14.00 |
| Aug 9, 2024 | Barrington Research | Michael Petusky | Outperform | Upgrade | $35.00 |
| May 6, 2024 | Lake Street | Brooks O'Neil | Buy | Upgrade | $50.00 |
| Feb 26, 2024 | Barrington Research | Michael Petusky | Market Perform | Downgrade | $N/A |
| Feb 23, 2024 | Deutsche Bank | Pito Chickering | Hold | Downgrade | $40.00 |
| Feb 23, 2024 | Jefferies | Brian Tanquilut | Hold | Downgrade | $39.00 |
| Nov 6, 2023 | Barrington Research | Michael Petusky | Outperform | Maintains | $68.00 |
| Aug 7, 2023 | Barrington Research | Michael Petusky | Outperform | Reiterates | $58.00 |
| Aug 7, 2023 | Deutsche Bank | Pito Chickering | Buy | Maintains | $50.00 |
The following stocks are similar to ModivCare based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Modivcare Inc. has a market capitalization of $215,307 with a P/E ratio of 0.0x. The company generates $2.79B in trailing twelve-month revenue with a 15.1% profit margin.
Revenue growth is -7.4% quarter-over-quarter, while maintaining an operating margin of -3.8% and return on equity of +523.2%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Provides integrated healthcare services and solutions.
The company operates a technology-driven model that integrates various supportive care solutions tailored for public and private payors. It generates revenue primarily through contracts with Medicaid and Medicare programs by offering services such as non-emergency medical transportation, personal care assistance, and remote patient monitoring.
ModivCare Inc. was founded in 1996 and is headquartered in Denver, Colorado. It serves a diverse client base, including government entities, managed care organizations, insurers, and health systems, helping to improve access to essential healthcare services for vulnerable populations.
Healthcare
Medical Care Facilities
23,675
Mr. L. Heath Sampson CPA
United States
2003
Modivcare Inc. (OTCMKTS: MODVQ) has completed its financial restructuring and emerged from Chapter 11, reducing its funded debt by $1.1 billion, over 85% of prior levels.
Modivcare's emergence from Chapter 11 and significant debt reduction enhance its financial stability, likely boosting investor confidence and potential share value.
Modivcare Inc. announced that the U.S. Bankruptcy Court has confirmed its Plan of Reorganization, allowing the company to emerge from Chapter 11 in the coming weeks.
Modivcare's confirmed reorganization plan signals a path out of bankruptcy, potentially stabilizing operations and attracting investor confidence while improving future financial performance.
Investors looking for new opportunities as 2025 ends may consider penny stocks, which can offer potential growth options.
Penny stocks may offer high-risk, high-reward opportunities for investors looking to maximize year-end returns as 2025 closes, potentially impacting market volatility and trading strategies.
Modivcare Inc. (Nasdaq: MODV) has filed for voluntary Chapter 11 bankruptcy to strengthen its financial foundation while maintaining care access and improving outcomes for clients.
Modivcare's voluntary Chapter 11 filing signals a significant restructuring effort, which could impact its financial stability and operational capabilities, affecting investor confidence and share value.
Modivcare Inc. (Nasdaq: MODV) faces delisting proceedings from Nasdaq, notified on August 21, 2025, due to unspecified issues related to its common stock.
Modivcare's potential delisting from Nasdaq signals financial instability, which could lead to reduced investor confidence and a decline in stock value.
Bragar Eagel & Squire attorney Brandon Walker is urging investors who incurred losses in ModivCare (MODV) to reach out for potential legal options.
The news indicates potential legal issues for ModivCare, which could lead to financial losses for investors. Ongoing litigation may affect stock performance and investor sentiment.
Analyst forecasts for Modivcare Inc. (MODV) are not currently available. The stock is trading at $0.02.
According to current analyst ratings, MODV has 0 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $0.02. Always conduct your own research and consider your investment goals before making investment decisions.
Price predictions from Wall Street analysts for MODV are not currently available. The stock is trading at $0.02.
The company operates a technology-driven model that integrates various supportive care solutions tailored for public and private payors. It generates revenue primarily through contracts with Medicaid and Medicare programs by offering services such as non-emergency medical transportation, personal care assistance, and remote patient monitoring.
Price targets from Wall Street analysts for MODV are not currently available. The stock is trading at $0.02.
Price targets from Wall Street analysts for MODV are not currently available. The stock is trading at $0.02.
The overall analyst consensus for MODV is neutral. Out of 7 Wall Street analysts, 0 rate it as Buy, 1 as Hold, and 0 as Sell.
Stock price projections, including those for Modivcare Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.